After developing a stubborn cough and undergoing a blood test, parents of then 3-year-old Bridget were given the worst news a parent can receive.
Your child has cancer.
Bridget endured four rounds of chemotherapy, a bone marrow transplant and several months in isolation to beat cancer. Then, at age 6, she relapsed, and underwent many more months in hospital, undergoing aggressive treatment and a second bone marrow transplant to tackle her rare cancer.
“None of the kids who went through it the first time with Bridget are alive now.”
Bridget had a rare, life-threatening form of cancer called acute myeloid leukaemia, which is particularly difficult to treat due to its resistance to chemotherapy and high rate of recurrence.
“Bridget’s relapse meant she had to stop dancing, swimming, gymnastics and school; it meant relocating as a family and being away from friends and pets once again. But now, she is back at home, enjoying school and living life as the beautiful girl she is.”
Acute myeloid leukaemia (AML) is an extremely rare form of cancer which affects the blood and bone marrow. Accounting for less than 1 percent of all diagnosed cancers, more funding is needed to ensure research continues to save the lives of young children like Bridget.